CA2420374A1 — Process for production of biopterin compound
Assigned to Asubio Pharma Co Ltd · Expires 2003-02-24 · 23y expired
What this patent protects
Transformed cells having been transformed in the presence of at least one gene of an enzyme participating in the biosynthesis of tetrahydrobiopterin; and a process for producing biopterins by using these cells. Thus, biopterins can be industrially advantageously produced in a lar…
USPTO Abstract
Transformed cells having been transformed in the presence of at least one gene of an enzyme participating in the biosynthesis of tetrahydrobiopterin; and a process for producing biopterins by using these cells. Thus, biopterins can be industrially advantageously produced in a large amount from less expensive materials.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.